Haemonetics HAE Cash Flow Statement
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| —— | $167.68M+42.6% | $117.56M+1.9% | $115.4M+166% | ||
| $111.72M-3.3% | $115.59M+18.9% | $97.22M+4.2% | $93.31M-4.5% | ||
| $33.83M+14.1% | $29.64M+4.6% | $28.33M+10.7% | $25.58M+5.0% | ||
| $293.22M+61.4% | $181.73M-0.3% | $182.29M-33.2% | $273.06M+58.5% | ||
| $32.78M-16.5% | $39.28M+3.0% | $38.13M-80.1% | $191.33M+98.2% | ||
| $60.18M— | —— | $243.85M— | —— | ||
| -$179.55M— | —— | -$322.39M-124% | -$143.79M-66.5% | ||
| —— | —— | —— | $75M— | ||
| $0— | —— | $0— | $0— | ||
| $0-100% | $4.69M-61.7% | $12.25M+27.3% | $9.63M-45.0% | ||
| -$180.49M— | —— | —— | -$100.36M-537% | ||
| -$64.85M— | —— | -$105.67M-523% | $24.97M-62.8% | ||
| $260.44M+82.8% | $142.45M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Haemonetics's cash flow data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.